Cerus to Host AABB Workshop on INTERCEPT Platelets and Fibrinogen Complex
Cerus Corporation announced it will hold an industry workshop at the 2026 AABB Annual Meeting in Atlanta. The workshop will cover implementation and real-world experience with INTERCEPT Platelets and INTERCEPT Fibrinogen Complex. The meeting is scheduled for October 17 through October 19.
Expanded Detail
EXPANDED:
Cerus Corporation, listed on Nasdaq as CERS, will host a workshop for industry participants at the 2026 AABB Annual Meeting. The session will examine how INTERCEPT Platelets and INTERCEPT Fibrinogen Complex have been put into use and what practical experience with them has revealed.
The gathering will be held in Atlanta, Georgia, from October 17 to October 19. AABB's yearly meeting brings together healthcare professionals, scientists
Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Related stories
NeOnc Adds Banking Executive to Board as Brain Cancer Program Advances in Abu Dhabi · Cancer research
Pfizer to Present More Than 50 Infectious Disease Abstracts at IDWeek 2026 · Infectious disease
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting.” Browse more stories.